Clinical Trials
154 trialsSpotlight
Astellas Pharma Inc
COMBI-AD
Novartis
GLOW
Astellas Pharma Inc
TRANSFORM-1
AbbVie
AcceleRET-Lung
Hoffmann-La Roche
FALCON
AstraZeneca
COLUMBUS
Pfizer
Bintrafusp Alfa Program Rollover Study
EMD Serono
COSMIC-312
Exelixis
VITAL
Brigham and Women's Hospital
COSMIC-313
Exelixis
LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
Novartis
JAVELIN Renal 101
Pfizer
PROStep
Abramson Cancer Center at Penn Medicine
ATHENA
pharmaand GmbH
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy
Alliance for Clinical Trials in Oncology
EURTAC
Spanish Lung Cancer Group
SOLAR-1
Novartis
MIST
Alliance for Clinical Trials in Oncology
CheckMate 7FL
Bristol-Myers Squibb
OPTIMA
Imunon
A Study in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Subjects, Excluding Those With the 17p Deletion, to Evaluate Debulking Regimens Prior to Initiating Venetoclax Combination Therapy
AbbVie
GAMMA
NantCell, Inc.
INDUCE-3
GlaxoSmithKline
TRIM-Line
Ottawa Hospital Research Institute
A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Helsinn Healthcare SA
A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Helsinn Healthcare SA
Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients
Kyowa Kirin Co., Ltd.
Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)
Amgen
A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer
Hoffmann-La Roche
TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer
Tavanta Therapeutics
MONALEESA-3
Novartis
CanStem303C
Sumitomo Pharma America, Inc.
CanStem43L
Sumitomo Pharma America, Inc.
CanStem111P
Sumitomo Pharma America, Inc.
A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy
Sumitomo Pharma America, Inc.
apact
Celgene
Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)
GTx
Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer
NuCana plc
SPRAY
Jazz Pharmaceuticals
Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain
Jazz Pharmaceuticals
VITA
Gradalis, Inc.
VENICE I
AbbVie
A Study of the Effectiveness of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Setting in Patients With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy
AbbVie
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Amgen
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
Amgen
Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer
Amgen
PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy
Amgen
Trybeca-1
ERYtech Pharma
Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone
Amgen